Annovis Bio schedules investor webcast for June 11 to discuss Buntanetap progress

Annovis Bio, Inc.

Webcast scheduled for June 11, 2024 at 4:30pm ET; registration via Zoom link provided.
Topics include recent Buntanetap developments, upcoming clinical trial plans, and company progress.
Buntanetap is a late-stage drug candidate for Alzheimer's and Parkinson's diseases.
No specific data or results disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.